Alliance Pharma Books £46m Impairment Charge Related To US Menopause Supplement

 
• By Tom Gallen

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

• Source: Shutterstock

More from Earnings

More from Business